Ocular Therapeutix (OCUL) Treasury Shares (2013 - 2025)
Ocular Therapeutix (OCUL) posted quarterly Treasury Shares of $4.4 million for Q4 2025, up 28.61% year-over-year from $3.4 million in Q4 2024, and up 28.61% on a QoQ basis from $3.4 million in Q4 2024.
Ocular Therapeutix (OCUL) Treasury Shares (2013 - 2025) Analysis & Trends
Ocular Therapeutix has reported Treasury Shares for 6 years, with the latest figure at $4.4 million in Q4 2025.
- Treasury Shares for Q4 2025 came in at $4.4 million, up 28.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.4 million (up 28.61% YoY), and the FY2025 annual result was $4.4 million, up 28.61% from the prior year.
- Treasury Shares grew to $4.4 million in Q4 2025, from $3.4 million in the prior quarter.
- Over five years, Treasury Shares peaked at $4.4 million in Q4 2025 and troughed at $1.1 million in Q4 2022.
- A 4-year average of $2.6 million and a median of $2.5 million in 2023 frame the typical range for Treasury Shares.
- The widest annual swing landed in 2024, when Treasury Shares surged 108.29%; it then grew 28.61% in 2025.
- A 4-year view of Treasury Shares shows it stood at $1.1 million in 2022, then surged by 48.93% to $1.6 million in 2023, then surged by 108.29% to $3.4 million in 2024, then gained by 28.61% to $4.4 million in 2025.
- Per Business Quant data, the three most recent Treasury Shares figures were $4.4 million in Q4 2025, $3.4 million in Q4 2024, and $1.6 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Ocular Therapeutix | 2.20 Bn | 2.20 Bn | 11.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.50 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 3.39 Mn |
| Dec 31, 2024 | 3.39 Mn |
| Dec 31, 2023 | 1.63 Mn |
| Dec 31, 2023 | 1.63 Mn |
| Dec 31, 2022 | 1.09 Mn |
| Dec 31, 2022 | 1.09 Mn |
| Dec 31, 2014 | 28,437.00 |
| Dec 31, 2014 | 28,437.00 |
| Jun 30, 2014 | 32.84 Mn |
| Jun 30, 2014 | 32.84 Mn |
| Dec 31, 2013 | 32.84 Mn |
| Dec 31, 2013 | 32.84 Mn |